Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Fostair

- PMLiVE

AstraZeneca shares late-stage results for Airsupra in mild asthma patients

More than ten million asthma exacerbations occur in the US every year

- PMLiVE

AstraZeneca’s triple-combination COPD therapy shows promise in uncontrolled asthma

Up to 262 million people worldwide are affected by the chronic respiratory disease

Digital PI Compliance

Why Pharma’s Digital PI Compliance Problem Needs a Cross-Functional Fix

In many pharma teams, the responsibility for keeping prescribing information (PI) up to date online falls into a grey area. > Regulatory signs it off. > Marketing publishes it. >...

Genetic Digital

QR codes for prescribing info

Leveraging the ABPI QR Code Update: Enhancing Prescribing Information Through Best Practices

ABPI's recent update permits QR codes in printed pharmaceutical materials for prescribing information. By ensuring visibility, providing clear instructions, linking directly, and keeping content current, companies can enhance accessibility, ensure...

Genetic Digital

Pi 360 – Digital PI & QR Code Tool

Pi 360 – A Smarter, Automated Solution for Digital Prescribing Information (PI) & QR Code Compliance

Life sciences digital agency Genetic Digital has launched Pi 360, a cutting-edge web application designed to help pharmaceutical companies automate the creation, management and distribution of Prescribing Information (PI) while...

Genetic Digital

- PMLiVE

Chiesi report highlights incorrect inhaler use among UK asthma patients

The long-term lung condition affects around 7.2 million people in the UK

- PMLiVE

Gilead and LEO enter inflammatory disease partnership worth up to $1.7bn

Targeting STAT6 has shown potential in treating a broad population of inflammatory disease patients

- PMLiVE

UK researchers uncover first new asthma and COPD attack treatment in 50 years

The phase 2 study showed that benralizumab could be re-purposed for use in emergency settings

- PMLiVE

AstraZeneca/Avillion share positive phase 3 results for asthma rescue treatment Airsupra

The chronic respiratory disease is estimated to affect up to 262 million people globally

- PMLiVE

ABPI highlights importance of NHS-industry partnerships in improving patient outcomes

Hospitals engaging in industry partnerships were found to be up to 2.5 times more likely to follow NICE guidelines

- PMLiVE

Chiesi Group invests €400m to establish biotech centre of excellence in Italy

The facility is dedicated to developing and producing monoclonal antibodies, enzymes and other proteins

- PMLiVE

2024 updates to the ABPI Code of Practice Clause 12

Iain Shield (Associate Director – Market Access, Mtech Access) has reviewed the changes to the ABPI Code of Practice, and highlights updates to prescribing information (Clause 12) and considerations around...

Petauri Evidence

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links